Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ju Yin cream is an investigational topical cream for **acne vulgaris**. It was evaluated together with oral Baidi Quzhi granule in the registered randomized, double-blind, multicenter Phase 3 study NCT05035979, sponsored by Shanghai Yueyang Integrated Medicine Hospital. Public trial materials refer inconsistently to Ju Yin and Ju Ying cream, while identifying the intervention abbreviation as JY cream. Its active composition, molecular targets, and pharmacologic mechanism have not been publicly disclosed; it should therefore be treated as a distinct named topical investigational product rather than mapped to a known INN or conventional acne drug. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05035979))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ju Yin cream.